SCHEMBL841784

SCHEMBL841784

CC(=O)c1cccc(S(=O)(=O)C(F)(F)F)c1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.55
LMNA P02545 3/20 0.55
KMT2A Q03164 2/20 0.51
MEN1 O00255 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.46
P2RX1 P51575 1/20 0.45
RXFP1 Q9HBX9 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.43
POLB P06746 1/20 0.43
HTT P42858 1/20 0.43
ACLY P53396 1/20 0.42
HTR2A P28223 1/20 0.42
TSPO P30536 1/20 0.42
GPR183 P32249 1/20 0.42
APLNR P35414 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22951476 0.84 ALDH1A1 (0.56) ALDH1A1LMNAKMT2AMEN1SMN1; SMN2
SCHEMBL14101261 0.84 ALDH1A1 (0.56) ALDH1A1LMNAKMT2AMEN1SMN1; SMN2
SCHEMBL1449037 0.84 F2 (0.53) ALDH1A1KMT2AMEN1POLBCA1
SCHEMBL29937265 0.84 F2 (0.53) ALDH1A1KMT2AMEN1POLBCA1
SCHEMBL1421819 0.83 P2RX1 (0.45) ALDH1A1LMNAKMT2AMEN1SMN1; SMN2
SCHEMBL2786905 0.83 GAA (0.51) ALDH1A1LMNAP2RX1RXFP1L3MBTL1
SCHEMBL28667831 0.82 POLB (0.51) ALDH1A1KMT2ARXFP1POLBACLY
SCHEMBL19364408 0.82 LOX (0.49) ALDH1A1KMT2AMEN1P2RX1RXFP1
SCHEMBL4093243 0.80 ALDH1A1 (0.55) ALDH1A1LMNAKMT2AMEN1SMN1; SMN2
SCHEMBL8519013 0.79 ALDH1A1 (0.57) ALDH1A1LMNAKMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2176223-B1 MALONAMIDE DERIVATIVES WITH ANTITHROMBOTIC ACTIVITY SANOFI SA (FR) 2013-01-23 EP disclosed
US-8143242-B2 Malonamide derivatives with antithrombotic activity SANOFI-AVENTIS (FR) 2012-03-27 US disclosed
US-20100249101-A1 MALONAMIDE DERIVATIVES WITH ANTITHROMBOTIC ACTIVITY SANOFI-AVENTIS (FR) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249101-A1 MALONAMIDE DERIVATIVES WITH ANTITHROMBOTIC ACTIVITY F7, F9, TFPI ALDH1A1 293/4885LMNA 546/4885KMT2A 1346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.